|
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
|
||
|
Form 20-F_X___
|
Form 40-F_______
|
|
|
|
||
|
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
|
||
|
|
Yes______
|
No___X___
|
|
|
||
|
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
|
||
|
|
Yes______
|
No___X___
|
|
|
||
|
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule12g3-2(b) under the Securities Exchange Act of 1934.
|
||
|
|
Yes______
|
No___X___
|
|
|
||
|
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82 N/A
|
||
|
|
ICON plc
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Brendan Brennan
|
|
Date: November 22, 2021
|
Brendan Brennan
|
|
Chief Financial Officer
|
ICON Releases Environmental, Social and Governance Report
The report looks to the future of ESG for the new ICON while highlighting advancements made in 2020
DUBLIN--(BUSINESS WIRE)--November 22, 2021--ICON plc (NASDAQ:ICLR) announced today the release of its 2020 Environmental, Social and Governance (ESG) Report. With the completion of ICON’s acquisition of PRA Health Sciences, the report presents a unified overview of the ESG advancements of both legacy organisations during 2020 and sets out the commitments, policies, and outlook for the combined company.
The ESG Report is available at: https://www.iconplc.com/about/esg/
“As a combined company, new ICON is focused on continuing to develop its ESG strategy and initiatives,” said ICON CEO Steve Cutler. “This report may be a look back to 2020, but it also demonstrates the great promise of the two organisations joining together to become the healthcare intelligence partner of choice. New ICON will continue to make a positive social and environmental impact and pursue our ESG goals and targets.”
For more information about ICON’s ESG efforts, please visit https://www.iconplc.com/about/esg/.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government
and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 37,960 employees in 159 locations in 53 countries as of
September 30, 2021. For further information about ICON, visit: www.iconplc.com and www.iconplc.com/pra.
ICON/ICLR-G
Contacts
Media:
Laurie Hurst
Sr Director, Public Relations & Communications
+1 919-274-3189
Laurie.Hurst@iconplc.com
Kate Haven
Vice President Investor Relations +1-888-381-7923
IR@iconplc.com